In recent years, a large number of coiled-coil proteins localised to the Go
lgi apparatus have been identified using antisera from human patients with
a variety of autoimmune conditions [1]. Because of their common method of d
iscovery and extensive regions of coiled-coil, they have been classified as
a family of proteins, the golgins [1]. This family includes golgin-230/245
/256, golgin-97, GM130/golgin-95, golgin-160/MEA-2/GCP170, giantin/macrogol
gin and a related group of proteins possibly splice variants - GCP372 and G
CP364 [2-11]. GM130 and giantin have been shown to function in the p115-med
iated docking of vesicles with Golgi cisternae [12]. In this process, p115,
another coiled-coil protein, is though to bind to giantin on vesicles and
to GM130 on cisternae, thus acting as a tether holding the two together [12
,13]. Apart from giantin and GM130, none of the golgins has yet been assign
ed a function in the Golgi apparatus. In order to obtain clues as to the fu
nctions of the golgins, the targeting to the Golgi apparatus of two members
of this family, golgin-230/245/256 and golgin-97, was investigated. Each o
f these proteins was shown to target to the Golgi apparatus through a carbo
xyterminal domain containing a conserved tyrosine residue, which was critic
al for targeting. The domain preferentially bound to nabs on protein blots,
and mutations that abolished Golgi targeting resulted in a loss of this in
teraction. Sequence analysis revealed that a family of coiled-coil proteins
from mammals, worms and yeast contain this domain at their carboxyl termin
i. One of these proteins, yeast Imh1p, has previously been shown to have a
tight genetic interaction with Rab6 [14]. On the basis of these data, it is
proposed that this family of coiled-coil proteins functions in nabs-regula
ted membrane-tethering events.